<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-KEN25187-ND9-02-2S9"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>111 S977 IS: End Taxpayer Funding of Gender Experimentation Act of 2025</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2025-03-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>119th CONGRESS</congress><session>1st Session</session><legis-num>S. 977</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20250312">March 12, 2025</action-date><action-desc><sponsor name-id="S411">Mr. Marshall</sponsor> (for himself, <cosponsor name-id="S395">Mrs. Hyde-Smith</cosponsor>, <cosponsor name-id="S398">Mr. Cramer</cosponsor>, <cosponsor name-id="S399">Mr. Hawley</cosponsor>, <cosponsor name-id="S417">Mr. Budd</cosponsor>, <cosponsor name-id="S293">Mr. Graham</cosponsor>, <cosponsor name-id="S435">Mr. Sheehy</cosponsor>, <cosponsor name-id="S396">Mrs. Blackburn</cosponsor>, <cosponsor name-id="S429">Mr. Banks</cosponsor>, <cosponsor name-id="S318">Mr. Wicker</cosponsor>, <cosponsor name-id="S346">Mr. Lee</cosponsor>, <cosponsor name-id="S410">Ms. Lummis</cosponsor>, and <cosponsor name-id="S323">Mr. Risch</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To prohibit taxpayer-funded gender transition procedures, and for other purposes.</official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause"><section commented="no" section-type="section-one" id="S1"><enum>1.</enum><header>Short title; table of contents</header><subsection commented="no" display-inline="no-display-inline" id="id391e25c325984c328ba2ca04b3f83a04"><enum>(a)</enum><header display-inline="yes-display-inline">Short title</header><text display-inline="yes-display-inline">This Act may be cited as the <quote><short-title>End Taxpayer Funding of Gender Experimentation Act of 2025</short-title></quote>.</text></subsection><subsection id="H1AA5F574E8314F9E98EE7C13CC5644DC"><enum>(b)</enum><header>Table of contents</header><text>The table of contents of this Act is as follows:</text><toc><toc-entry level="section" idref="S1">Sec. 1. Short title; table of contents.</toc-entry><toc-entry level="title" idref="HC37FE777AEF64780B508E083947D4382">TITLE I—Prohibiting federally funded gender transition procedures</toc-entry><toc-entry level="section" idref="H52B7D4371E114F0EAFE91E16D7BCD160">Sec. 101. Prohibiting taxpayer-funded gender transition procedures.</toc-entry><toc-entry level="section" idref="HA95543D479B24850A00F415BE49255DB">Sec. 102. Amendment to table of chapters.</toc-entry><toc-entry level="title" idref="H642E2FAF8A01448586AFAEC8EAC098D3">TITLE II—Application under the Affordable Care Act</toc-entry><toc-entry level="section" idref="H0DE80340EC61478EA6649B070AEA1BCC">Sec. 201. Clarifying application of prohibition to premium credits and cost-sharing reductions under ACA.</toc-entry></toc></subsection></section><title id="HC37FE777AEF64780B508E083947D4382"><enum>I</enum><header>Prohibiting federally funded gender transition procedures</header><section id="H52B7D4371E114F0EAFE91E16D7BCD160"><enum>101.</enum><header>Prohibiting taxpayer-funded gender transition procedures</header><text display-inline="no-display-inline">Title 1, United States Code, is amended by adding at the end the following new chapter:</text><quoted-block style="USC" display-inline="no-display-inline" id="HCD7D56C57E844E7EAA171A2CA40CCFDC"><chapter id="H2D6D7BC1808F4DD2AE75FFE3A6E27517"><enum>4</enum><header>Prohibiting taxpayer-funded gender transition procedures</header><toc><toc-entry level="section">Sec. </toc-entry><toc-entry level="section" idref="HA07074918092475091E3EAF2AC1C39B6">301. Prohibition on funding for gender transition procedures. </toc-entry><toc-entry level="section" idref="H195BC353E3E443E1A77779D73C740F8A">302. Prohibition on funding for health benefits plans that cover gender transition procedures. </toc-entry><toc-entry level="section" idref="H39127A4AA4324232A427209B0CF20A59">303. Limitation on Federal facilities and employees. </toc-entry><toc-entry level="section" idref="HB672573A8BDB4BDEA74C40B6554FCB7B">304. Construction relating to separate coverage. </toc-entry><toc-entry level="section" idref="H6CB9520898244D3B8531BF311FC34376">305. Construction relating to the use of non-Federal funds for health coverage. </toc-entry><toc-entry level="section" idref="HA5B2E8930C7F475A8D139ECABC2A3F9F">306. Construction relating to complications arising from gender transition procedures. </toc-entry><toc-entry level="section" idref="HB118F4BA1FCC43C19DDEC48968FD9D39">307. Definitions. </toc-entry></toc><section id="HA07074918092475091E3EAF2AC1C39B6"><enum>301.</enum><header>Prohibition on funding for gender transition procedures</header><text display-inline="no-display-inline">No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for any gender transition procedures.</text></section><section id="H195BC353E3E443E1A77779D73C740F8A"><enum>302.</enum><header>Prohibition on funding for health benefits plans that cover gender transition procedures</header><text display-inline="no-display-inline">No funds authorized or appropriated by Federal law, and none of the funds in any trust fund to which funds are authorized or appropriated by Federal law, shall be expended for health benefits coverage that includes coverage of gender transition procedures.</text></section><section id="H39127A4AA4324232A427209B0CF20A59"><enum>303.</enum><header>Limitation on Federal facilities and employees</header><text display-inline="no-display-inline">No health care service furnished—</text><paragraph id="H5A4B7A956E344E84802395D62EE12BDA"><enum>(1)</enum><text>by or in a health care facility owned or operated by the Federal Government; or</text></paragraph><paragraph id="H851FA455E9BC4334B645098FF8477DBA"><enum>(2)</enum><text>by any physician or other individual employed by the Federal Government to provide health care services within the scope of the physician’s or individual’s employment,</text></paragraph><continuation-text continuation-text-level="section">may include gender transition procedures. </continuation-text></section><section id="HB672573A8BDB4BDEA74C40B6554FCB7B"><enum>304.</enum><header>Construction relating to separate coverage</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed as prohibiting any individual, entity, or State or locality from purchasing separate coverage for gender transition procedures or health benefits coverage that includes gender transition procedures so long as such coverage is paid for entirely using only funds not authorized or appropriated by Federal law and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.</text></section><section id="H6CB9520898244D3B8531BF311FC34376"><enum>305.</enum><header>Construction relating to the use of non-Federal funds for health coverage</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed as restricting the ability of any non-Federal health benefits coverage provider from offering coverage for gender transition procedures, or the ability of a State or locality to contract separately with such a provider for such coverage, so long as only funds not authorized or appropriated by Federal law are used and such coverage shall not be purchased using matching funds required for a federally subsidized program, including a State’s or locality’s contribution of Medicaid matching funds.</text></section><section id="HA5B2E8930C7F475A8D139ECABC2A3F9F"><enum>306.</enum><header>Construction relating to complications arising from gender transition procedures</header><text display-inline="no-display-inline">Nothing in this chapter shall be construed to apply to the treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of a gender transition procedure. </text></section><section id="HB118F4BA1FCC43C19DDEC48968FD9D39"><enum>307.</enum><header>Definitions</header><text display-inline="no-display-inline">For purposes of this chapter:</text><paragraph id="idfebc6d47b3744fa49470fde0f41e0df6"><enum>(1)</enum><header>Female</header><text>The term <term>female</term>, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. </text></paragraph><paragraph id="id1efd4e7c915f47b4bb6aec5e054b5771"><enum>(2)</enum><header>Gender transition</header><text>The term <term>gender transition</term> means the process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex, and may be accompanied with social, legal, or physical changes. </text></paragraph><paragraph id="id33a80afcd82141e986eff5bd00f81c64"><enum>(3)</enum><header>Gender transition procedure</header><subparagraph id="id3c0c4d5f98bb4acb8b8c5bf385c00576"><enum>(A)</enum><header>In general</header><text>The term <term>gender transition procedure</term> means any hormonal or surgical intervention for the purpose of gender transition, including— </text><clause id="id6a6cd84b4cc44ea8b1953324238a3537" commented="no"><enum>(i)</enum><text>gonadotropin-releasing hormone (GnRH) agonists or other puberty-blocking or suppressing drugs to stop or delay normal puberty; </text></clause><clause id="id0ea296c2e70a41f480f2e516c4b4bab4" commented="no"><enum>(ii)</enum><text>testosterone, estrogen, progesterone, or other androgens to an individual at doses that are supraphysiologic to what would normally be produced endogenously in a healthy individual of the same age and sex;</text></clause><clause id="id762a1b0e374b4b9aa409f7a9dda10ea8"><enum>(iii)</enum><text>castration;</text></clause><clause id="idcbb3e9e72e7a45afb41359b0bf11e6ab"><enum>(iv)</enum><text>orchiectomy;</text></clause><clause id="idf791928ea8f74f0495c981dcb6b6f3ef"><enum>(v)</enum><text>scrotoplasty;</text></clause><clause id="id9910f2b568934bf4801e6380a5f45061"><enum>(vi)</enum><text>implantation of erection or testicular prostheses;</text></clause><clause id="id3cafc55e88b1477d81b6b84fa63adcfc"><enum>(vii)</enum><text>vasectomy;</text></clause><clause id="id4d97fd5d8975437db2850acc5e6e6045"><enum>(viii)</enum><text>hysterectomy;</text></clause><clause id="id76100e22a0004f888ce8e2496a937302"><enum>(ix)</enum><text>oophorectomy;</text></clause><clause id="idbe67da0af1d3471b81acd95932b00e17"><enum>(x)</enum><text>ovariectomy;</text></clause><clause id="idc11bedf41d634c7a8dd65c18ccafcf57"><enum>(xi)</enum><text>reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty;</text></clause><clause id="id2bc562ef34ba4082b30e8f2806f58388"><enum>(xii)</enum><text>metoidioplasty;</text></clause><clause id="id14e1a58f133d4d40aeb95e2161bb7a1a"><enum>(xiii)</enum><text>penectomy;</text></clause><clause id="id06512adde6c548f4921b30fa2f925239"><enum>(xiv)</enum><text>phalloplasty;</text></clause><clause id="id9d2de722209f491aa86f941dd7b31014"><enum>(xv)</enum><text>vaginoplasty;</text></clause><clause id="id62a752454e744445aec694eb71b94d36"><enum>(xvi)</enum><text>clitoroplasty</text></clause><clause id="id379e0ecdc37d44ef9003d8315458b934"><enum>(xvii)</enum><text>vaginectomy;</text></clause><clause id="id7f39064daf7b486db4c0fe28c88cb32e"><enum>(xviii)</enum><text>vulvoplasty;</text></clause><clause id="idbd7e0d8c2d2942a1ae5f4c3c1b1ba3df"><enum>(xix)</enum><text>reduction thyrochondroplasty;</text></clause><clause id="idae6937209a354baf85bde36e4ed18b1e"><enum>(xx)</enum><text>chondrolaryngoplasty;</text></clause><clause id="idd390ba8d8ae74c16bfc9fdf53b5cc894"><enum>(xxi)</enum><text>mastectomy;</text></clause><clause id="id3a50b0a2ae4849a6b0319a4306af2311"><enum>(xxii)</enum><text>tubal ligation;</text></clause><clause id="id74e90e2d7e814afcb1608b21ce8c6da9"><enum>(xxiii)</enum><text>sterilization;</text></clause><clause id="idc52c59d5c2d14e9caba98dd138bba458"><enum>(xxiv)</enum><text>any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual;</text></clause><clause id="id3c2fafdf2953464b98102d65c22e264c"><enum>(xxv)</enum><text>any placement of chest implants to create feminine breasts;</text></clause><clause id="id605da9288e894641b28e5ad5b01b6d25"><enum>(xxvi)</enum><text>any placement of fat or artificial implants in the gluteal region;</text></clause><clause id="ida43696ffcf444c98af45ebe1448ae48d"><enum>(xxvii)</enum><text>augmentation mammoplasty;</text></clause><clause id="idca18f468406644d6be9a9834e70b37ee"><enum>(xxviii)</enum><text>liposuction; </text></clause><clause id="idb500e2ed78724f9a8af00583a93d94e2"><enum>(xxix)</enum><text>lipofilling;</text></clause><clause id="id0febff1cb1a545f6bacb243c58c25ab5"><enum>(xxx)</enum><text>voice surgery;</text></clause><clause id="id3aae7324b1b242e2b1327781c67a9879"><enum>(xxxi)</enum><text>hair reconstruction;</text></clause><clause id="id2c645ead5af94083ae85867450914470"><enum>(xxxii)</enum><text>pectoral implants; and</text></clause><clause id="id5bfb75a86b004bf08428fa57b5c6a15a" commented="no"><enum>(xxxiii)</enum><text>the removal of any otherwise healthy or non-diseased body part or tissue. </text></clause></subparagraph><subparagraph id="ida6ecdc46d20a48cc8752bcb9bd39b9eb"><enum>(B)</enum><header>Exclusions</header><text>The term <term>gender transition procedure</term> does not include the following when furnished to an individual by a health care provider with the consent of such individual or, if applicable, such individual’s parents or legal guardian:</text><clause id="id787efb7100074ffd9e64fb10deda7b32"><enum>(i)</enum><text>Services to individuals born with a medically verifiable disorder of sex development, including an individual with external sex characteristics that are irresolvably ambiguous, such as an individual born with 46 XX chromosomes with virilization, an individual born with 46 XY chromosomes with undervirilization, or an individual born having both ovarian and testicular tissue.</text></clause><clause id="id771aeaec4c0c44ea83c4fccc94a58d2c"><enum>(ii)</enum><text>Services provided when a physician has otherwise diagnosed a disorder of sexual development in which the physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a healthy individual of the same sex and age.</text></clause><clause id="id9501a8e7b56845bcb1922bcecd6378d4" commented="no" display-inline="no-display-inline"><enum>(iii)</enum><text>The treatment of any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of gender transition procedures, whether or not the gender transition procedure was performed in accordance with State and Federal law or whether or not funding for the gender transition procedure is permissible under this section.</text></clause><clause id="id713045bad369430f8701ab49e675bf8b"><enum>(iv)</enum><text>Any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness (but not mental, behavioral, or emotional distress or a mental, behavioral, or emotional disorder) that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function, unless the procedure is performed. </text></clause><clause id="id67955ba3109945a08721378b1555c4fb"><enum>(v)</enum><text>Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty.</text></clause><clause id="id67705788dd0e4387afb6e8d4377f2746"><enum>(vi)</enum><text>Male circumcision.</text></clause></subparagraph></paragraph><paragraph id="id6075631d97f9498292a9a7620c44d891"><enum>(4)</enum><header>Male</header><text>The term <term>male</term>, when used to refer to a natural person, means an individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. </text></paragraph><paragraph id="idefdc7474692943ab9ba44ef41f8d548c" commented="no" display-inline="no-display-inline"><enum>(5)</enum><header>Sex</header><text>The term <term>sex</term>, when referring to an individual’s sex, means to refer to either male or female, as biologically determined.</text></paragraph></section></chapter><after-quoted-block>.</after-quoted-block></quoted-block></section><section id="HA95543D479B24850A00F415BE49255DB"><enum>102.</enum><header>Amendment to table of chapters</header><text display-inline="no-display-inline">The table of chapters for title 1, United States Code, is amended by adding at the end the following new item:</text><quoted-block style="USC" display-inline="no-display-inline" id="HAFEEA1F380AB498D8B0F87E0BDCE21B4"><toc regeneration="no-regeneration"><multi-column-toc-entry bold="on" level="section"><toc-enum>4. </toc-enum><level-header bold="on" level="section">Prohibiting taxpayer-funded gender transition procedures</level-header><target>301</target></multi-column-toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></section></title><title id="H642E2FAF8A01448586AFAEC8EAC098D3"><enum>II</enum><header>Application under the Affordable Care Act</header><section id="H0DE80340EC61478EA6649B070AEA1BCC"><enum>201.</enum><header>Clarifying application of prohibition to premium credits and cost-sharing reductions under ACA</header><subsection display-inline="no-display-inline" id="H6B42E1EC68394AAAAC74D3FCA14FA996"><enum>(a)</enum><header>In general</header><paragraph id="H37BAEB6C8860482A834A4C1858E3A49F"><enum>(1)</enum><header>Disallowance of refundable credit and cost-sharing reductions for coverage under qualified health plan which provides coverage for gender procedures</header><subparagraph id="H7E28F811940C4447983D28DD80CD1914"><enum>(A)</enum><header>In general</header><text>Subparagraph (A) of <external-xref legal-doc="usc" parsable-cite="usc/26/36B">section 36B(c)(3)</external-xref> of the Internal Revenue Code of 1986 is amended by inserting before the period at the end the following: <quote>or any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, United States Code (other than any procedure described in section 306 of such title)</quote>.</text></subparagraph><subparagraph id="H690F5E3CDA9349749F96BB5469F6F0A7"><enum>(B)</enum><header>Option to purchase or offer separate coverage or plan</header><text display-inline="yes-display-inline">Paragraph (3) of section 36B(c) of such Code is amended by adding at the end the following new subparagraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HA3726A2D89804EF0A7661BF34298BEA6"><subparagraph id="H1FDD7EE2C3B64D6DBAD610252DE7E1EB"><enum>(C)</enum><header>Separate coverage or plan for gender transition procedures allowed</header><clause id="HE45BAC6CE2A8463DBD06F3933B3E12B1"><enum>(i)</enum><header>Option to purchase separate coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall be construed as prohibiting any individual from purchasing separate coverage for gender transition procedures described in such subparagraph, or a health plan that includes such gender transition procedures, so long as no credit is allowed under this section with respect to the premiums for such coverage or plan.</text></clause><clause id="H60CB4EC4E2DF414FB2F6EC8685305816"><enum>(ii)</enum><header>Option to offer coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender transition procedures described in such subparagraph, or a plan that includes such gender transition procedures, so long as premiums for such separate coverage or plan are not paid for with any amount attributable to the credit allowed under this section (or the amount of any advance payment of the credit under section 1412 of the Patient Protection and Affordable Care Act).</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H7D9C27C513D3420AB6D3BBC39ADBB5DC"><enum>(2)</enum><header>Disallowance of small employer health insurance expense credit for plan which includes coverage for gender transition procedures</header><text>Subsection (h) of <external-xref legal-doc="usc" parsable-cite="usc/26/45R">section 45R</external-xref> of the Internal Revenue Code of 1986 is amended—</text><subparagraph display-inline="no-display-inline" id="H7F9FC83392FD4064A995D97D0DEB7D3D"><enum>(A)</enum><text>by striking <quote>Any term</quote> and inserting the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H830165352A784DEEB5AEF04A322D6312"><paragraph id="H644383919A8D41A1B4314EE826B13B6C"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Any term</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph id="H5A051F72AA914D0BA1762210FE487D9D"><enum>(B)</enum><text>by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H3C913A111B7041DD977B821ABE31033E"><paragraph id="HA82D0E5ED5B64CF08605AF4F0BC5D176"><enum>(2)</enum><header>Exclusion of health plans including coverage for gender transition procedures</header><subparagraph id="HD2F80CFCF6BE416CABBC945287168603"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">In this section, the term <term>qualified health plan</term> does not include any health plan that includes coverage for gender transition procedures, as defined in section 307 of title 1, United States Code (other than any procedure described in section 306 of such title).</text></subparagraph><subparagraph id="H633B515D7B4547C3AA9B25F7ABA8C388"><enum>(B)</enum><header>Separate coverage or plan for gender transition procedures allowed</header><clause display-inline="no-display-inline" id="H61A805050D054F258CD39774AF7C2589"><enum>(i)</enum><header>Option to purchase separate coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall be construed as prohibiting any employer from purchasing for its employees separate coverage for gender transition procedures described in such subparagraph, or a health plan that includes such gender transition procedures, so long as no credit is allowed under this section with respect to the employer contributions for such coverage or plan.</text></clause><clause id="H53CF98624B674DDD9B0CDB339D68A174"><enum>(ii)</enum><header>Option to offer coverage or plan</header><text display-inline="yes-display-inline">Nothing in subparagraph (A) shall restrict any non-Federal health insurance issuer offering a health plan from offering separate coverage for gender transition procedures described in such subparagraph, or a plan that includes such gender transition procedures, so long as such separate coverage or plan is not paid for with any employer contribution eligible for the credit allowed under this section.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection><subsection id="H2DDB1BAC2ED645D49C86323BB4250033"><enum>(b)</enum><header>Application to multi-State plans</header><text>Section 1334(a) of <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref> (<external-xref legal-doc="usc" parsable-cite="usc/42/18054">42 U.S.C. 18054(a)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HE4D1F5923F6C49D8AF184D18C4D4EDCC"><paragraph id="H1FEE24B6C9D842E69F6B97CDFE494033"><enum>(8)</enum><header>Coverage consistent with Federal policy regarding gender transition procedures</header><text display-inline="yes-display-inline">In entering into contracts under this subsection, the Director shall ensure that no multi-State qualified health plan offered in an Exchange provides health benefits coverage for which the expenditure of Federal funds is prohibited under <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/1/4">chapter 4</external-xref> of title 1, United States Code.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection commented="no" display-inline="no-display-inline" id="HF9EEEF7612E24689B6BD8DCA764A01BD"><enum>(c)</enum><header>Effective date</header><text display-inline="yes-display-inline">The amendments made by subsection (a) shall apply to taxable years ending after the date that is 1 year after the date of enactment of this Act, but only with respect to plan years beginning after such date, and the amendment made by subsection (b) shall apply to plan years beginning after such date. </text></subsection></section></title></legis-body></bill> 

